Interchangeable Endotoxin-Binding Domains in Proteins with Opposite Lipopolysaccharide-Dependent Activities

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5599-5605

  Schumann, Ralf R ^a   Lamping, Norbert ^a   Hoess, Adolf ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MorphoSys AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTILIPOPOLYSACCHARIDE FACTOR (LIMULUS); ANTIMICROBIAL CATIONIC PEPTIDE; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CARRIER PROTEIN; CD14 ANTIGEN; HORMONE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; PLASMA PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CHO CELL; EPITOPE MAPPING; HAMSTER; METABOLISM; MOLECULAR CLONING; NEUTROPHIL; POINT MUTATION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CARRIER PROTEINS; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; EPITOPE MAPPING; INVERTEBRATE HORMONES; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEUTROPHILS; POINT MUTATION; RECOMBINANT PROTEINS;

EID: 0031298184     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Raetz, C. R. H. 1990. Bacterial endotoxins. Annu. Rev. Biochem. 59:129.
2. Rietschel, E., T. Kirikae, U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. Ulmer, U. Zähringer, U. Seydel, F. DiPadova, M. Schreier, and H. Brade. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217.
3. Rietschel, E. T., and H. Brade. 1992. Bacterial endotoxins. Sci. Am. 267:54.
4. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437.
5. Parillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471.
6. Wright, S. D., S. M. Levin, M. T. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169:175.
7. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
8. Wright, S. D., R. A. Ramos, M. Patel, and D. S. Miller. 1992. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J. Exp. Med. 176:719.
9. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429.
10. Hailman, E., T. Vasselon, M. Kelley, L. A. Busse, M. C. T. Hu, H. S. Lichenstein, P. A. Detmers, and S. D. Wright. 1996. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156: 4384.
11. Ulevitch, R. J. 1993. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53:267.
12. Galanos, C., O. Luederitz, E. T. Rietschel, O. Westphal, H. Brade, L. Brade, M. Freudenberg, U. Schade, M. Imoto, and H. Yoshimura. 1985. Synthetic and natural Escherichia coli-free lipid A express identical endotoxic activities. Eur. J. Biochem. 145:1.
13. Gallay, P., D. Heumann, D. LeRoy, C. Barras, and M. P. Glauser. 1993. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc. Natl. Acad. Sci. USA 90:9935.
14. Schumann, R. R., C. Kirschning, A. Unbehaun, H. Aberle, H.-P. Knopf, N. Lamping, R. J. Ulevitch, and F. Hermann. 1996. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol. Cell. Biol. 16:3490.
15. Hailman, E., H. S. Lichtenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD 14. J. Exp. Med. 179:269.
16. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482.
17. Morrison, D. C., M. G. Lei, T. Kirikae, and T. Y. Chen. 1993. Endotoxin receptors on mammalian cells. Immunbiology 187:212.
18. Aketagawa, J., T. Miyata, S. Ohtsubo, T. Nakamura, T. Morita, H. Hayashida, T. Miyata, S. Iwanaga, T. Takao, and Y. Shimonishi. 1986. Primary structure of Limulus anticoagulant anti-lipopolysaccharide factor. J. Biol. Chem. 261:7357.
19. Kloczewiak, M., K. M. Black, P. Loiselle, J. M. Cavaillon, N. Wainwright, and H. S. Warren. 1994. Synthetic peptides that mimic the binding site of horseshoe crab anti-lipopolysaccharide factor. J. Infect. Dis. 170:1490.
20. Larrick, J. W., M. Hirata, H. Zheng, J. Zhong, D. Bolin, J. M. Cavaillon, H. S. Warren, and S. C. Wright. 1994. A novel granulocyte-derived peptide with LPS-neutralizing activity. J. Immunol. 152:231.
21. Hailman, E., J. J. Albers, G. Wolfbauer, A. Y. Tu, and S. D. Wright. 1996. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 217:12172.
22. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1979. New function for high density lipoproteins: their participation in intravascular reactions of bacterial lipopolysaccharides (LPS). J. Clin. Invest. 64:1516.
23. Hampton, R. Y., D. T. Golenbeck, M. Penman, M. Krieger, and C. R. H. Raetz. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352::342.
24. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. deBoer, D. M. MacLaren, J. deGraaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628.
25. Gray, P. W., G. Flaggs, S. R. Leong, R. J. Gumina, J. Weiss, C. E. Ooi, and P. Elsbach. 1989. Cloning of the cDNA of a human neutrophil bactericidal protein: structural and functional correlations. J. Biol. Chem. 264:9505.
26. Elsbach, P., and J. Weiss. 1993. Bactericidal/permeability increasing protein and host defense against Gram-negative bacteria and endotoxin. Curr. Opin. Immunol. 5:103.
27. Kohn, F. R., and A. H. Kung. 1995. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infect. Immun. 63:333.
28. Dentener, M. A., E. J. Von Asmuth, G. J. Francot, M. N. Marra, and W. A. Buurman. 1993. Involvement of CD 14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J. Immunol. 151:4258.
29. Nelson, D., N. Kuppermann, G. R. Fleisher, B. K. Hammer, C. M. Thompson, C. T. Garcia, T. J. Novitsky, J. Parsonnet, and G. R. Siber. 1995. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats. Crit. Care Med. 23:92.
30. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA 90:12040.
31. Hoess, A., S. Watson, G. R. Siber, and R. Liddington. 1993. Crystal structure of an endotoxin-neutralizing protein from horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J. 12:3351.
32. Hoess, A., J. Schneider-Mergener, and R. Liddington. 1995. Identification of the LPS-binding domain of an endotoxin neutralizing protein, Limulus anti-LPS factor. Prog. Clin. Biol. Res. 392:327.
33. Ried, C., C. Wahl, T. Miethke, G. Wellnhofer, C. Landgraf, J. Schneider-Mergener, and A. Hoess. 1996. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-LPS factor. J. Biol. Chem. 271:28120.
34. Taylor, A. H., G. Heavner, M. Nedelman, D. Sherris, E. Brunt, D. Knight, and J. Ghrayeb. 1995. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270:17934.
35. Lamping, N., A. Hoess, B. Yu, T. C. Park, C. Kirschning, D. Pfeil, D. Reuter, S. D. Wright, F. Herrmann, and R. R. Schumann. 1996. Functional characterization of the lipopolysaccharide (LPS) binding site of LPS binding protein (LBP) by site-directed mutagenesis. J. Immunol. 157:4648.
36. Little, R. G., D. N. Keiner, E. Lim, D. J. Burke, and P. J. Conlon. 1994. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J. Biol. Chem. 269:1865.
37. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312:839.
38. Ooi, C. E., J. Weiss, M. E. Doerfler, and P. Elsbach. 1991. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J. Exp. Med. 174:649.
39. Gazzano-Santoro, S. H., J. B. Parent, L. Grinna, A. H. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon. 1992. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60: 4754.
40. Theofan, G., A. H. Horwitz, R. E. Williams, P. S. Liu, I. Chan, C. Birr, S. F. Carroll, K. Meszaros, J. B. Parent, and H. Kasler. 1994. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J. Immunol. 152:3623.
41. Han, J., J. C. Mathison, R. J. Ulevitch, and P. S. Tobias. 1994. Lipopolysaccharide (LPS) binding protein, truncated at IIe-197, binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269:8172.
42. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1989. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264:10867.
43. Troelstra, A., B. N. G. Giepmans, K. P. M. Van Kessel, H. S. Liechenstein, J. Verhoef, and J. A. G. Van Strijp. 1997. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukocyte Biol. 61:173.
44. Thornton, J. M., M. S. Edwards, W. R. Taylor, and D. J. Barlow. 1986. Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J. 5:409.
45. Barlow, D. J., M. S. Edwards, and J. M. Thornton. 1986. Continuous and discontinuous protein antigenic determinants. Nature 322:747.
46. Sexton, J. L., M. C. Wilce, T. Colin, G. L. Wijffels, L. Salvatore, S. Feil, M. W. Parker, T. W. Spithill, and C. A. Morrison. 1994. Vaccination of sheep against Fasciola hepatica with glutathione S-transferase: identification and mapping of antibody epitopes on a three-dimensional model of the antigen. J. Immunol. 152:1861.
47. Hoess, A., and R. C. Liddington. 1993. LPS-binding and neutralizing peptides. International Patent PCT. US94/02465, and PCT, WO95/05393.
48. Anderson, B. F., H. M. Baker, G. E. Norris, D. W. Rice, and E. N. Baker. 1989. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 angstroms resolution. J. Mol. Biol. 209:711.
49. Moran, E. 1988. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products. Nature 334:168.
50. Yu, B., and S. D. Wright. 1995. Catalytic properties of lipopolysaccharide (LPS) binding protein (LBP). I. Transfer of LPS to soluble CD14. J. Biol. Chem. 271: 4100.